U.S. FDA Cuts Gap For Moderna COVID-19 Booster Dose To Five Months
On friday, the U.S. Food and Drug Administration shortened from at least five months to a month the interval between primary series and boosters of the Moderna COVID-19 vaccine for people aged 18 and over. The most effective way to prevent most cases of COVID-19, including all the circulating variants, is vaccination. By reducing the